151 related articles for article (PubMed ID: 12209643)
1. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.
Maeda A; Maeda T; Ohguro H; Palczewski K; Sato N
Eur J Immunol; 2002 Aug; 32(8):2300-7. PubMed ID: 12209643
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
Maeda A; Maeda T; Liang Y; Yenerel M; Saperstein DA
Mol Vis; 2006 Aug; 12():885-91. PubMed ID: 16917481
[TBL] [Abstract][Full Text] [Related]
3. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
[TBL] [Abstract][Full Text] [Related]
4. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic retinopathy and anti-recoverin antibodies].
Bataller L; Graus F; Dalmau J
Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
[No Abstract] [Full Text] [Related]
7. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
9. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
[TBL] [Abstract][Full Text] [Related]
11. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
12. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
13. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
15. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
Adamus G
Autoimmun Rev; 2003 Mar; 2(2):63-8. PubMed ID: 12848960
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoma-associated retinopathy: a review with clinical examples].
Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
[TBL] [Abstract][Full Text] [Related]
20. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
Adamus G; Amundson D; MacKay C; Gouras P
Arch Ophthalmol; 1998 Feb; 116(2):251-3. PubMed ID: 9488286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
